Q3 2024 LabSense News

What's new in the issue below:

Acquisition- KLAR Partners Acquires BÜHLMANN Laboratories AG
New Partnership-Worldwide Collaboration with Beckman Coulter Dx
Poster Corner- BÜHLMANN posters from IFCC WorldLab 2024
Recent & Upcoming Meetings- IFCC WorldLab, ADLM, AMLI

What's New?

BÜHLMANN Laboratories AG Acquired by KLAR Partners to Support the Continued Growth of the Company

BÜHLMANN Laboratories AG (“BÜHLMANN”) announces the closing of the acquisition by funds advised by KLAR Partners Limited (“KLAR Partners” or “KLAR”) June 5th, 2024. The acquisition enables BÜHLMANN to support its future as a leading independent specialty in-vitro diagnostics company.

Read press release

BÜHLMANN Laboratories AG Announces Worldwide Collaboration with Beckman Coulter Dx for BÜHLMANN fCAL® turbo and fPELA turbo®

BUHLMANN Diagnostics Corp, is pleased to announce the collaboration with Beckman Coulter Diagnostics (BCI) for a worldwide distribution of the BÜHLMANN fCAL® turbo assay & BÜHLMANN fPELA® turbo assay on their clinical chemistry AU series analyzers (AU480, AU680, AU5800, DxC 700AU and DxC 500AU).

Explore the benefits & details of this collaboration

Learn more

Technical News

All Things CALEX® Cap

CALEX Cap 4.0- Improved Total Laboratory Automation (TLA), or Block Automation & Seamless Integration

Revolutionize your lab with our latest innovation in TLA compatibility and Block Automation, now with extended extract stability—approved for fCAL® turbo. Streamline your workflow, protect your staff, and ensure sample integrity. Explore the full benefits and watch the transformation in action here.

BÜHLMANN fCAL® turbo + CALEX Cap is (K191718 & K232057)): FDA 510(k) cleared. For in vitro Diagnostic Use.

Poster Corner

Posters Presented in May at the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) WorldLab 2024 Congress- Dubai, UAE

P1550: A Recombinant Fusion Protein that Mimics the Inflammatory Biomarker Calprotectin as a Tool to Harmonize MRP-8/MRP8/14 Immunoassays

Download Poster

BÜHLMANN sCAL® turbo assay is for Research Use Only. Not for diagnostic procedures in the US.

P0993: Clinical Performance of Turbidimetric Immunoassay for the quantification of Fecal Pancreatic Elastase

Download Poster

BÜHLMANN fPELA® turbo is for Research Use Only. Not for diagnostic procedures in the US.

P070: Regulatory Conform Replacement of Triton-X in an Anti-MAG Antibodies ELISA- The Impact of Different Detergents on Performance and Stability

Download Poster

Anti-MAG Antibodies ELISA (Myelin Associated Glycoprotein) is for Research Use Only. Not for diagnostic procedures in the US.

Events

Recent

IFCC WorldLab 2024- Dubai, UAE

View the BÜHLMANN Educational Workshop Presentations

Clinical value of calprotectin in the diagnosis and management of patients suffering from IBD– Prof. Jordi Guardiola

Explore the clinical importance of fecal calprotectin levels and how they influence the management of IBD patients.

Fecal Calprotectin testing in routine lab work: the experience from a reference center – Rouba Trad

Learn from a reference center's experience on how to implement fecal calprotectin testing into automated and optimized laboratory workflow and how to overcome analytical and pre-analytical challenges.

Calprotectin: Insights into biological function & biochemical analysis – Dr. Alexander Ohmann

Gain an understanding of the interesting and complex biochemistry of calprotectin and its significance as an important player in the innate immune system.